Feb 9, 2015, 12:00 PM by Michael Croft

Bio-IT World | Reference Genomics, one of the first biotech startups funded by Silicon Valley's famous seed accelerator Y Combinator, is trying to revamp how microbial geneticists search through large reference databases of genomes with its online platform One Codex.

Feb 6, 2015, 00:00 AM by Michael Croft

New York Times | Researchers at Weill Cornell Medical College mapped DNA found in New York's subway system, finding that almost half the genetic material did not match any known organism.

Feb 4, 2015, 12:15 PM by Michael Croft

Bio-IT World | The National Human Genome Research Institute has announced an update to its Informed Consent Resource, to reflect its new preference for obtaining the "broadest possible sharing permissions" for genomic data as studies increasingly rely on very large patient cohorts to understand personal health risks.

Feb 4, 2015, 00:00 AM by Michael Croft

BASEL, SWITZERLAND - Feb 4, 2015 -  Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced its Combination Screening Colloquium at the 4th Annual Society for Laboratory Automation and Screening (SLAS) Conference and Exhibition in Washington, DC (February 8)

Feb 3, 2015, 12:00 PM by Michael Croft

Feb 3, 2015, 11:30 AM by Michael Croft

New York Times | In the wake of President Obama's proposal for a coordinated Precision Medicine Initiative, Gina Kolata writes that the program's real promise is not mass sequencing or data collection, but a database architecture that would allow patient information from multiple research projects to be smoothly combined.

Feb 3, 2015, 10:40 AM by Michael Croft

Bio-IT World | News and product releases from around the industry, including new analysis technology for Sequenom's non-invasive prenatal tests.

Feb 3, 2015, 00:00 AM by Michael Croft

DUBAI, UNITED ARAB EMIRATES - Feb 3, 2015 - In today’s brutally competitive world, what sets businesses apart is their approach and use of predictive analytics and smart data

Feb 2, 2015, 10:40 AM by Michael Croft

Bio-IT World | Semiconductor sequencing, the basis for the Ion Torrent line of whole genome sequencers, has been a bit of a flop on the market, but the technology's inventor Chris Toumazou is betting big on miniaturization at his company DNA Electronics — starting anew with point-of-care tests for infectious disease.

Jan 30, 2015, 06:00 AM by Michael Croft

Jan 30, 2015, 00:00 AM by Michael Croft

New England Journal of Medicine | Francis Collins and Harold Varmus discuss the President's Personalized Medicine Initiative.

Jan 29, 2015, 10:00 AM by Michael Croft

Jan 29, 2015, 00:00 AM by Michael Croft

PRINCETON, NJ - Jan 29, 2015 - Certara®, the global biosimulation technology-enabled drug development and drug safety consulting company, today announced that it has promoted Amin Rostami, Pharm

Jan 28, 2015, 11:25 AM by Michael Croft

Bio-IT World News Brief | The long courtroom fights are at long last coming to an end as Myriad Genetics has announced it will settle its complex web of suits and countersuits and end claims to ownership of certain genetic testing targets and methods.

Jan 28, 2015, 00:00 AM by Michael Croft

Xconomy | Cambridge, MA-based Exosome Diagnostics aims to raise $25 million, on top of the $27 million in Series B funding it raised last March. Exosome would use the cash to launch its first two products: a blood-based test for lung cancer, and a urine test for prostate cancer.

Jan 27, 2015, 00:00 AM by Michael Croft

CHAPEL HILL, NC, UNITED STATES - Jan 27, 2015 - WHAT:  Rho, a full-service contract research organization (CRO), will highlight its continued success in drug development strategies and services during the Outsourcing in Clinical Trials (OCT) West Coast conference, being held February 3-4 in Burlingame, California

Jan 27, 2015, 00:00 AM by Michael Croft

Bloomberg | Google Inc., expanding its foray into medical research, will join multiple sclerosis drugmaker Biogen Idec Inc. to study environmental and biological contributors to the debilitating disease's progression.

Jan 27, 2015, 00:00 AM by Michael Croft

- Jan 27, 2015 - Potassium channels are attractive therapeutic targets for treatment of cardiovascular and cancer diseases which are the top two public-health problems for the aging population

Jan 26, 2015, 11:00 AM by Michael Croft

Jan 26, 2015, 10:35 AM by Michael Croft

Xconomy | Yumanity, a well-connected drug discovery startup, plans to play the long game in drug development by using yeast models in deep phenotypic screens to study neurological diseases based on protein misfolding.